... Like insulin aspart (NovoLog) — the product it’s based on — Merilog helps manage blood sugar spikes around mealtime for people living with diabetes. This approval marks the third insulin biosimilar available in the U.S., offering another option that may lead to more affordable diabetes care. ...
First Fast-Acting Insulin Biosimilar Could Lower Diabetes Treatment Costs
... Like insulin aspart (NovoLog) — the product it’s based on — Merilog helps manage blood sugar spikes around mealtime for people living with diabetes. This approval marks the third insulin biosimilar available in the U.S., offering another option that may lead to more affordable diabetes care. ...